Stay updated on Dupilumab in Prurigo Nodularis: Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Prurigo Nodularis: Clinical Trial page.

Latest updates to the Dupilumab in Prurigo Nodularis: Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedAn additional publication citation was added to the Publications section, and the page revision tag was updated to v3.5.4.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page’s display footer was updated to show a new ClinicalTrials.gov site revision (v3.5.3 instead of v3.5.2). This reflects a back-end/site version update rather than any change to the study information.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. This appears to be a minor version update with no visible changes to page content or functionality.SummaryDifference0.0%

- Check55 days agoChange DetectedNew publication citation added: Stander et al. Dupilumab Improves Prurigo Activity and Severity in Patients with Prurigo Nodularis: A Post Hoc Analysis of Pooled Results from the PRIME and PRIME2 Trials (Dermatol Ther, 2026).SummaryDifference0.0%

- Check69 days agoChange Detected- Updated site revision from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check84 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed from the page. No study content is affected.SummaryDifference0.0%

Stay in the know with updates to Dupilumab in Prurigo Nodularis: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Prurigo Nodularis: Clinical Trial page.